Assessment of health status in patients with newly diagnosed chronic obstructive pulmonary disease

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Gao, Yongping ^a   Hou, Qi ^b   Wang, Haoyan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PREDICTION; PREVALENCE; SCORING SYSTEM; SMOKING; SPIROMETRY;

AGED; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84891953638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082782     Document Type: Article

References (15)

1. Jemal A, Ward E, Hao Y, Thun M (2005) Trends in the leading causes of death in the United States, 1970-2002. JAMA 294:1255-1259. doi: 10.1001/jama.294.10.1255. PubMed: 16160134. (Pubitemid 41352114)
2. Barnes PJ (2004) Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56:515-548. doi:10.1124/pr.56.4.2. PubMed: 15602009. (Pubitemid 39658462)
3. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775-789. doi: 10.1056/NEJMoa063070. PubMed: 17314337. (Pubitemid 46294610)
4. Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z et al. (2008) The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 177:19-26. doi:10.1164/rccm. 200707-973OC. PubMed: 17916806.
5. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J (2008) Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 63:402-407. doi:10.1136/thx.2007.085456. PubMed: 18234906. (Pubitemid 351692346)
6. Omori H, Nonami Y, Mihara S, Marubayashi T, Morimoto Y et al. (2007) Prevalence of airflow limitation on medical check-up in Japanese subjects. J UOEH 29:209-219. PubMed: 17900001.
7. American Thoracic Society (1995) Standardization of Spirometry, 1994. Update - Am J Respir Crit Care Med 152:1107-1136. doi:10.1164/ajrccm.152.3. 7663792.
8. Global Strategy for Diagnosis Management, and Prevention of COPD Available online at: [http://www.goldcopd.org/guidelines-global- strategyfordiagnosis-management.html].
9. Jinping Zheng (2002) A nationwide questionnaire survey on clinical application of pulmonary function testing in China. Zhonghua Jie He He Hu Xi Za Zhi 25:69-73. PubMed: 11953100.
10. Guping Chen (2007) Significance of Pulmonary Function Test in Chronic Obstructive Pulmonary Disease Diagnose. J Clin Res 24:1326-1328.
11. Ulrik CS, Løkke A, Dahl R, Dollerup J, Hansen G, et al. (2011) Early detection of COPD in general practice. Int J Chron Obstruct Pulmon Dis 6:123-127 doi: 10.2147/COPD. S16929.
12. Kelly JL, Bamsey O, Smith C, Lord VM, Shrikrishna D et al. (2012) Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration 84:193-199. doi:10.1159/000336549. PubMed: 22441322.
13. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR et al. (2012) Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 185:1218-1224. doi:10.1164/rccm.201110-1843OC. PubMed: 22281834.
14. Jones PW (2009) Health status and the spiral of decline. COPD 6:59-63. doi:10.1080/15412550802587943. PubMed: 19229709.
15. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW et al. (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581-586. doi:10.1136/thx.54.7.581. PubMed: 10377201. (Pubitemid 29296676)